News
Amid India’s shifting economic landscape, sectoral mutual funds offer sharp, theme-based exposure. This article breaks down ...
China's growing biotech prowess has become a real threat to the industry in the US in recent years. Moves by the Trump administration could weaken the US market further, according to several experts ...
Kennedy said that Pallone had previously been a champion of people who had been harmed by vaccines and only changed his tune ...
U.S. District Chief Judge F. Dennis Saylor IV of the District of Massachusetts ordered Janssen Biotech, a wholly owned ...
A House Energy and Commerce Subcommittee on Health hearing came to a brief halt Tuesday as the Republican chair asked Health ...
The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug ...
In today’s media landscape, you know what outrages me the most? Seeing those repetitive, dreamlike and misleading ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, ...
For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of ...
StockStory.org on MSN9d
Drug Development Inputs & Services Stocks Q1 Recap: Benchmarking Fortrea (NASDAQ:FTRE)As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & ...
Biogen has emerged as a potential front-runner at the Cannes Lions International Festival of Creativity, snagging four spots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results